SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
|
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |||||
| Common Shares From Convertible Debentures And Related Accrued Interest | 53,309 | 53,309 | 52,839 | ||
| Share based compensation expenses, grant in period | 497,744 | 392,365 | 1,068,374 | 1,367,389 | |
| Current Federal Deposit Insurance | $ 250,000 | ||||
| External Expenses | $ 381,000 | $ 281,000 | 644,000 | $ 520,000 | |
| Internal Expenses | 327,000 | 187,000 | 881,000 | 595,000 | |
| Amortization Of The R & D Obligation | $ 270,000 | $ 0 | $ 407,085 | $ 0 | |
| Common Shares Issuable Upon The Exercise Of Outstanding Stock Options And Warrants | 6,084,205 | 6,084,205 | 6,344,868 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|